한글목차

세계 Drug Discovery 기술 시장은 2018년 414억 4,530만 달러로 평가되었으며, 2023년까지 연평균 9.0% 이상 성장할 것으로 예상됩니다.

제약 연구개발(R&D) 지출 증가

신약 연구개발에 대한 제약기업의 지출 증가는 지난 기간 동안 Drug Discovery 기술 시장의 성장을 이끌었습니다. 제약회사들은 기술 혁신과 의료 격차 해소를 위해 연구개발(R&D)에 많은 투자를 했습니다. 이러한 투자는 첨단 신약 개발 기술의 채택을 촉진하고 개발 프로세스를 간소화했습니다. 예를 들어, 세계 제약사들은 2022년 연구개발에 총 1,390억 달러를 투자했습니다. 또한 2019년 세계 제약사들은 평균적으로 매출액의 약 25%를 연구개발에 투자했습니다. 따라서 제약업계의 R&D 비용 증가는 Drug Discovery 기술 시장의 성장을 뒷받침했습니다.

목차

제1장 주요 요약

• Drug Discovery 기술 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장의 정의
• 개요
• Drug Discovery 기술 시장 정의와 세분화
• 시장 세분화 : 기술별
  • High Throughput Screening(HTS)
  • 유전체학
  • 바이오인포매틱스
  • 조합화학
  • 바이오칩
  • 바이오 분석 기기
  • 기타 기술
• 시장 세분화 : 의약품 유형별
  • 저분자 의약품
  • 생물학적 제제
• 시장 세분화 : 질환 용도별
  • 암 질환
  • 면역 질환
  • 신경 질환
  • 심혈관 질환
  • 기타 질환 용도별
• 시장 세분화 : 최종사용자별
  • 제약회사
  • 바이오의약품 기업
  • 바이오테크놀러지 기업
  • 연구기관
  • 기타 최종사용자

제7장 주요 시장 동향

제8장 Drug Discovery 기술 시장 : 거시경제 시나리오

• COVID-19의 영향 : Drug Discovery 기술 시장
• 우크라이나 전쟁의 영향 : Drug Discovery 기술 시장
• 고인플레이션의 영향 : Drug Discovery 기술 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033년
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 Drug Discovery 기술 시장 : 세분화

• 세계의 Drug Discovery 기술 시장 : 기술별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 Drug Discovery 기술 시장 : 약 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 Drug Discovery 기술 시장 : 최종사용자별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 Drug Discovery 기술 시장 : 질환 용도별, 분석과 예측, 2018-2023년, 2028년, 2033년

제11장 Drug Discovery 기술 시장 : 지역/국가별 분석

• 세계의 Drug Discovery 기술 시장 : 지역별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 Drug Discovery 기술 시장 : 국가별, 분석과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• AstraZeneca plc
• Merck KGaA
• GlaxoSmithKline plc
• Pfizer Inc
• Thermo Fisher Scientific Inc

제20장 기타 주요 기업 및 혁신 기업

• Waters Corporation
• Bio-Rad Laboratories
• GE Healthcare Ltd.
• Novartis AG
• Bruker Corporation
• Curia Global Inc.
• AbbVie Inc.
• Bayer AG
• Agilent Technologies, Inc.
• Sanofi S.A
• Beckman Coulter Inc.
• Evotec AG
• Luminex Corporation
• Standard BioTools Inc.
• Caliper Life Sciences Inc.

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 인수합병(M&A)

• Ampersand Biomedicines Acquired AbCheck
• Sygnature Discovery Acquired SB Drug Discovery
• Charles River Laboratories International Acquired SAMDI Tech
• Verseon Acquired Edammo
• Bayer Acquired Vividion Therapeutics

제24장 기회와 전략

• 세계의 Drug Discovery 기술 시장(2028년) : 새로운 기회를 제공하는 국가
• 세계의 Drug Discovery 기술 시장(2028년) : 새로운 기회를 제공하는 부문
• 세계의 Drug Discovery 기술 시장(2028년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제25장 Drug Discovery 기술 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

Drug discovery technologies encompass a range of tools, methodologies and processes employed in the identification and development of new pharmaceutical compounds. This market is integral to the pharmaceutical and biotechnology industries, providing essential support for the discovery of both small molecule drugs and biologic drugs.

The drug discovery technologies market consists of revenues earned by entities (organizations, sole traders and partnerships) from sales of drug discovery technologies that include a range of scientific approaches and methodologies aimed at identifying and developing new pharmaceuticals for treating diseases.

The global drug discovery technologies market was valued at $41,445.3 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 9.0%.

Increased Pharmaceutical Research And Development (R&D) Expenditure

The increased pharmaceutical spending on research and development of new drugs drove the growth of the drug discovery technologies market during the historic period. Pharmaceutical firms invested significantly in research and development (R&D) to innovate and address medical gaps. This investment drove adoption of advanced drug discovery tech, streamlining development processes. For example, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Also in 2019, globally pharmaceutical companies spent an average of roughly 25% of their revenue on R&D. Therefore, the increased research and development expenditure in pharmaceutical supported the growth of the drug discovery technologies market.

Introduction Of Intelligent Robotics Labs To Expand AI-Driven Drug Discovery Efforts

The introduction of intelligent robotics labs marks a significant advancement in AI (artificial intelligence)-driven drug discovery efforts. These labs are equipped with automated high-throughput screening, which allows for the rapid testing of millions of compounds against specific drug targets. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery technologies, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.

The global drug discovery technologies market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 26.61% of the total market in 2022.

Drug Discovery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug discovery technologies market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug discovery technologies? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug discovery technologies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug discovery technologies market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type, by disease application and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the drug discovery technologies market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by drug type, by disease application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for drug discovery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Technology: High Throughput Screening; Genomics; Bioinformatics; Combinational Chemistry; Biochips; Bioanalytical Instruments; Other Technologies
• 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
• 3) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
• 4) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
• Companies Mentioned: AstraZeneca plc.; Merck KGaA; GlaxoSmithKline Plc; Pfizer Inc.; Thermo Fisher Scientific
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug discovery technologies indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Drug Discovery Technologies - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Drug Discovery Technologies Market Definition And Segmentations
• 6.4 Market Segmentation By Technology
  • 6.4.1 High Throughput Screening
  • 6.4.2 Genomics
  • 6.4.3 Bioinformatics
  • 6.4.4 Combinational Chemistry
  • 6.4.5 Biochips
  • 6.4.6 Bioanalytical Instruments
  • 6.4.7 Other Technologies
• 6.5 Market Segmentation By Drug Type
  • 6.5.1 Small Molecule Drugs
  • 6.5.2 Biologic Drugs
• 6.6 Market Segmentation By Disease Application
  • 6.6.1 Cancer Diseases
  • 6.6.2 Immunological Diseases
  • 6.6.3 Neurological Diseases
  • 6.6.4 Cardiovascular Diseases
  • 6.6.5 Other Disease Applications
• 6.7 Market Segmentation By End-User
  • 6.7.1 Pharmaceutical Companies
  • 6.7.2 Biopharmaceutical Companies
  • 6.7.3 Biotechnology Companies
  • 6.7.4 Research Institutes
  • 6.7.5 Other End-Users

7 Major Market Trends

• 7.1 Focus On Advanced Technologies To Accelerate Drug Development
• 7.2 Introduction Of Intelligent Robotics Labs To Expand AI-Driven Drug Discovery Efforts
• 7.3 Investments Focused On Development Of Drug Discovery Models
• 7.4 Strategic Partnerships And Collaborations Among Major Players

8 Drug Discovery Technologies Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Drug Discovery Technologies Market
• 8.2 Impact Of The War In Ukraine On The Drug Discovery Technologies Market
• 8.3 Impact Of High Inflation On The Drug Discovery Technologies Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Drug Discovery Technologies Market Segmentation

• 10.1 Global Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Drug Discovery Technologies Market, Segmentation By Disease Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Drug Discovery Technologies Market, Regional and Country Analysis

• 11.1 Global Drug Discovery Technologies Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Drug Discovery Technologies Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia-Pacific Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Drug Discovery Technologies Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Investments
  • 12.9.11 Major Companies
• 12.10 China Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Drug Discovery Technologies Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 Eastern Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Drug Discovery Technologies Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Drug Discovery Technologies Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.10 USA Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Drug Discovery Technologies Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Investments
  • 18.2.11 Major Companies
• 18.3 Africa Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• Company Profiles 288
• 19.1 AstraZeneca plc
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
  • 19.1.3 Business Strategy
  • 19.1.4 Financial Overview
• 19.2 Merck KGaA
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 GlaxoSmithKline plc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Pfizer Inc
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Thermo Fisher Scientific Inc
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Waters Corporation
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Bio-Rad Laboratories
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 GE Healthcare Ltd.
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Novartis AG
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Bruker Corporation
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Curia Global Inc.
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 AbbVie Inc.
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Bayer AG
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Agilent Technologies, Inc.
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Sanofi S.A
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Beckman Coulter Inc.
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Evotec AG
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Luminex Corporation
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Standard BioTools Inc.
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Caliper Life Sciences Inc.
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Ampersand Biomedicines Acquired AbCheck
• 23.2 Sygnature Discovery Acquired SB Drug Discovery
• 23.3 Charles River Laboratories International Acquired SAMDI Tech
• 23.4 Verseon Acquired Edammo
• 23.5 Bayer Acquired Vividion Therapeutics

24 Opportunities And Strategies

• 24.1 Global Drug Discovery Technologies Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Drug Discovery Technologies Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Drug Discovery Technologies Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Drug Discovery Technologies Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer